US FDA grants Fast Track designation for NPI-001 tablets for treatment of retinitis pigmentosa
January 22nd 2025Preclinical studies evaluating NPI-001 have found that it boosts the endogenous antioxidant glutathione, which stops chemically aggressive oxygen molecules from further damaging retinal cells, according to Nacuity Pharmaceuticals.
GSLS 2025: Scleral lens fitting in a keratoconus patient with a complex history
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
EnVision Summit 2025: A weekend for comanagement and all things eye care
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
Brainstorming eye care research expansion with unlimited resources
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.